← All Posts
Your medical affairs team publishes clinical trial results, real-world evidence summaries, and treatment guideline updates. You distribute them to physicians through rep visits, emails, and medical conferences.
Physician engagement with written medical content: declining every year. They have 7 minutes between patients. Reading a 12-page journal article isn’t happening.
Turn medical affairs content into podcast episodes physicians listen to during their commute:
Clinical trial summaries: Two hosts discuss the primary endpoints, safety data, and clinical significance. “The phase III trial showed [X] with a p-value of [Y]. Here’s what this means for your patients.”
Real-world evidence: “Post-marketing data from 50,000 patients shows [Z]. The second host asks: How does this change the risk-benefit conversation?”
Guideline updates: “The AHA updated its hypertension guidelines. Here are the three changes that affect your practice.”
Competitive landscape: “A competing therapy just published results. Here’s how they compare.”
Your therapy is approved in 40 countries. Medical affairs content is in English. Physicians in Japan, Germany, Brazil, Korea need it in their language.
Audio in 100+ languages from one set of clinical content. Compliant, consistent, and immediate — without commissioning translations.
The audio is generated from pre-approved text. Medical Legal Regulatory (MLR) reviews the source content. The audio is a faithful discussion of approved materials — no off-label claims, no unapproved indications.
Clinical evidence matters. Only if physicians hear it.